add KPV specifically for the gut inflammation component
Li, H., Li, B., Lv, D., Li, W., Lu, Y
By treating metabolically active adipocytes and hepatocytes with 5-amino-1-methylquinolinium, researchers can precisely inhibit intracellular NNMT activity, monitor changes in the nicotinamide pathway and NAD+ levels, and analyze effects on energy metabolism
It allows discussion of angiogenesis, endothelial signaling, nitric oxide context, and cell-migration models while avoiding consumer outcomes
Community reports align with this finding, with many users describing the stack as significantly more effective than monotherapy with either compound